DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Morschhauser F, Feugier P, Flinn IW, Gasiorowski RE, Greil R, Illés Á.
Venetoclax plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) improves outcomes in BCL2-positive first-line diffuse large B-cell lymphoma (DLBCL):First safety, efficacy and biomarker analyses from the phase II CAVALLI study.
Blood. 2018;
132: 782 et al. (supplement 1)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.